Welcome to LookChem.com Sign In|Join Free
  • or
(S)-2-cyclopropyl-2-((methoxycarbonyl)amino)acetic acid, a derivative of cyclopropyl glycine, is a chemical compound with the molecular formula C8H11NO4. It features a cyclopropyl group and a carbamate moiety, which is formed by the addition of a methoxycarbonyl group to the amino group of cyclopropyl glycine. (S)-2-cyclopropyl-2-((methoxycarbonyl)amino)acetic acid holds potential neuroprotective and analgesic properties, making it a promising candidate for pharmaceuticals and medicinal chemistry.

1007885-57-5

Post Buying Request

1007885-57-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1007885-57-5 Usage

Uses

Used in Pharmaceutical Industry:
(S)-2-cyclopropyl-2-((methoxycarbonyl)amino)acetic acid is used as a chemical intermediate for the development of new pharmaceuticals due to its unique structural and functional properties.
Used in Medicinal Chemistry:
(S)-2-cyclopropyl-2-((methoxycarbonyl)amino)acetic acid is used as a building block for the synthesis of novel compounds with potential therapeutic applications, particularly in the areas of neuroprotection and analgesia.
Used in Research and Development:
(S)-2-cyclopropyl-2-((methoxycarbonyl)amino)acetic acid is used as a subject of study in research and development to explore its potential as a therapeutic agent for various medical conditions, leveraging its neuroprotective and analgesic properties.

Check Digit Verification of cas no

The CAS Registry Mumber 1007885-57-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,8,8 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1007885-57:
(9*1)+(8*0)+(7*0)+(6*7)+(5*8)+(4*8)+(3*5)+(2*5)+(1*7)=155
155 % 10 = 5
So 1007885-57-5 is a valid CAS Registry Number.

1007885-57-5Relevant academic research and scientific papers

Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere

Rusere, Linah N.,Lockbaum, Gordon J.,Henes, Mina,Lee, Sook-Kyung,Spielvogel, Ean,Rao, Desaboini Nageswara,Kosovrasti, Klajdi,Nalivaika, Ellen A.,Swanstrom, Ronald,Kurt Yilmaz, Nese,Schiffer, Celia A.,Ali, Akbar

, p. 8296 - 8313 (2020)

The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C2-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2′ position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2′ position without significantly affecting potency. However, the group on the opposite P2/P2′ position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of the position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights into optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres.

Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitors

Dwyer, Michael P.,Keertikar, Kerry M.,Chen, Lei,Tong, Ling,Selyutin, Oleg,Nair, Anilkumar G.,Yu, Wensheng,Zhou, Guowei,Lavey, Brian J.,Yang, De-Yi,Wong, Michael,Kim, Seong Heon,Coburn, Craig A.,Rosenblum, Stuart B.,Zeng, Qingbei,Jiang, Yueheng,Shankar, Bandarpalle B.,Rizvi, Razia,Nomeir, Amin A.,Liu, Rong,Agrawal, Sony,Xia, Ellen,Kong, Rong,Zhai, Ying,Ingravallo, Paul,Asante-Appiah, Ernest,Kozlowski, Joseph A.

, p. 4106 - 4111 (2016/08/01)

A matched and mixed capping SAR study was conducted on the tetracyclic indole class of HCV NS5A inhibitors to examine the influence of modifications of this region on the overall HCV virologic resistance profiles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1007885-57-5